Anzeige
Mehr »
Samstag, 25.10.2025 - Börsentäglich über 12.000 News
Das nächste Lila Sciences? Telescope Innovations ist das 30-Millionen-Dollar-Tor zu KI-gesteuerter Chemie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1CY7H | ISIN: IL0010951403 | Ticker-Symbol:
NASDAQ
24.10.25 | 21:40
4,065 US-Dollar
+1,37 % +0,055
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SCISPARC LTD Chart 1 Jahr
5-Tage-Chart
SCISPARC LTD 5-Tage-Chart

Aktuelle News zur SCISPARC

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrSciSparc Ltd. - 6-K, Report of foreign issuer1
FrSciSparc acquires controlling stake in Neurothera Labs in asset deal1
FrSciSparc Ltd: SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio109TEL AVIV, Israel, Oct. 24, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
► Artikel lesen
DoSciSparc sells majority-owned cancer therapy subsidiary to N2OFF1
DoSciSparc Ltd: SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer131TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies...
► Artikel lesen
DoSciSparc stock jumps after launch of quantum computing initiative2
DoSciSparc launches quantum computing initiative for 3D protein modeling1
DoSciSparc Ltd: SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery2
SCISPARC Aktie jetzt für 0€ handeln
DoMiza III Ventures Inc: Miza III investor SciSparc acquires 63.3 million shares1
DoMiza III Ventures Inc: Miza III closes qualifying transaction with SciSparc1
MiScisparc Ltd. - Early Warning Regarding Acquisition Of Common Shares Of Neurothera Labs Inc.1
MoSciSparc Ltd: SciSparc-Clearmind Collaboration Leads to Publication of U.S. Patent Application Targeting Binge Behavior Disorders1
15.10.SciSparc Ltd. - 6-K, Report of foreign issuer2
15.10.SciSparc Shares Surge 32% After Announcing TSXV Acquisition Agreement1
15.10.SciSparc stock soars after deal to gain controlling stake in Miza III Ventures2
15.10.SciSparc-Aktie steigt nach Deal zur Mehrheitsübernahme von Miza III Ventures um 34,5 %3
15.10.SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures1
15.10.SciSparc to acquire controlling stake in Miza for $11.6 million1
15.10.SciSparc to acquire Miza III stake, transfer pharma portfolio; shares surge2
15.10.SciSparc Ltd: SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio101According to the agreement, SciSparc's pharmaceuticals assets and equity stake in SciSparc Nutraceuticals Inc. are valued at approximately US$11.6 million TEL AVIV, Israel, Oct. 15, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
Weiter >>
76 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1